AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $446,457 | -2.5% | 6,388 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $458,107 | +10.1% | 6,375 | -5.5% | 0.00% | 0.0% |
| Q1 2023 | $416,093 | -41.5% | 6,746 | -26.8% | 0.00% | 0.0% |
| Q4 2022 | $710,753 | +72.9% | 9,215 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $411,000 | -37.0% | 9,221 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $652,000 | +7.4% | 9,668 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $607,000 | -33.0% | 10,721 | -3.6% | 0.00% | -50.0% |
| Q4 2020 | $906,000 | +7.1% | 11,121 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $846,000 | -43.0% | 11,875 | -34.2% | 0.00% | -50.0% |
| Q2 2020 | $1,485,000 | +142.3% | 18,050 | +73.1% | 0.00% | +100.0% |
| Q1 2020 | $613,000 | -58.6% | 10,426 | -27.2% | 0.00% | -50.0% |
| Q4 2019 | $1,479,000 | – | 14,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |